After 34 cases of liver metastasis of breast cancer-related factor analysis.docVIP

After 34 cases of liver metastasis of breast cancer-related factor analysis.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
 PAGE \* MERGEFORMAT 5 After 34 cases of liver metastasis of breast cancer-related factor analysis [Abstract] Objective: To analyze the chemotherapy and hepatic artery embolization chemotherapy treatment for breast cancer the efficacy of postoperative liver metastasis and explore the factors affecting prognosis. Methods: 34 patients with metastatic breast cancer patients clinical characteristics, TACE compared to chemotherapy alone and chemotherapy efficacy and prognosis of the two methods. Results: 34 cases of breast cancer patients with postoperative liver metastasis, simple and effective systemic chemotherapy group 9 cases (42.9%), systemic chemotherapy and hepatic artery embolization chemotherapy group, 7 patients (53.8%), the whole group median follow-up period of 16 months (3 ~ 51 months), with a median survival time was 17 months. 1,2,3-year survival rates were 37%, 18%, 11%. Conclusion: The use of systemic chemotherapy and hepatic artery embolization chemotherapy treatment for breast cancer liver metastases after curative effect is better, worthy of further study. [Keywords:] breast cancer; metastatic liver cancer; hepatic artery embolization chemotherapy; [Abstract] Objective: To explore the efficacy of chemotherapy and transcatheter arterial chemoembolization on breast carcinoma postoperation with liver metastasis, and analyze prognostic factors initially. Methods: Clinical features of 34 breast carcinoma patients with liver metastasis, treated from 2000 to 2006, were analyzed retrospectively. The efficacies of different treatment approaches were compared. Results: The total responsive rates were 47.1% for all patients, 42.9% for the 21 patients received systemic chemotherapy, 53.8% for the 13 patients chemotherapy plus TACE. At a median follow-up of 16 (3 ~ 51 months), the median survival rate was 17, and the 1 -, 2 - ,3-year survival rates were 37%, 18% and 11% respectively. Conclusion: Chemotherapy plus TACE may be an effective treatment to post

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档